nodes	percent_of_prediction	percent_of_DWPC	metapath
Salbutamol—Cold symptoms—Octreotide—thymus cancer	0.115	0.115	CcSEcCtD
Salbutamol—Stomach ache—Octreotide—thymus cancer	0.0338	0.0338	CcSEcCtD
Salbutamol—Abdominal bloating—Octreotide—thymus cancer	0.0302	0.0302	CcSEcCtD
Salbutamol—Epigastric pain—Octreotide—thymus cancer	0.0298	0.0298	CcSEcCtD
Salbutamol—Appetite absent—Octreotide—thymus cancer	0.0289	0.0289	CcSEcCtD
Salbutamol—Ear disorder—Octreotide—thymus cancer	0.0267	0.0267	CcSEcCtD
Salbutamol—Gastrointestinal symptom NOS—Octreotide—thymus cancer	0.0245	0.0245	CcSEcCtD
Salbutamol—Otitis media—Octreotide—thymus cancer	0.0185	0.0185	CcSEcCtD
Salbutamol—Coagulopathy—Octreotide—thymus cancer	0.0185	0.0185	CcSEcCtD
Salbutamol—Breast pain—Octreotide—thymus cancer	0.0165	0.0165	CcSEcCtD
Salbutamol—Viral infection—Octreotide—thymus cancer	0.0159	0.0159	CcSEcCtD
Salbutamol—Herpes simplex—Octreotide—thymus cancer	0.0156	0.0156	CcSEcCtD
Salbutamol—Eructation—Octreotide—thymus cancer	0.0141	0.0141	CcSEcCtD
Salbutamol—Wheezing—Octreotide—thymus cancer	0.014	0.014	CcSEcCtD
Salbutamol—Cramps of lower extremities—Octreotide—thymus cancer	0.0132	0.0132	CcSEcCtD
Salbutamol—Hyperkinesia—Octreotide—thymus cancer	0.0125	0.0125	CcSEcCtD
Salbutamol—Diabetes mellitus—Octreotide—thymus cancer	0.012	0.012	CcSEcCtD
Salbutamol—Gastroenteritis—Octreotide—thymus cancer	0.0118	0.0118	CcSEcCtD
Salbutamol—Nasal congestion—Octreotide—thymus cancer	0.0115	0.0115	CcSEcCtD
Salbutamol—Injury—Octreotide—thymus cancer	0.0114	0.0114	CcSEcCtD
Salbutamol—Hypoglycaemia—Octreotide—thymus cancer	0.0107	0.0107	CcSEcCtD
Salbutamol—Irritability—Octreotide—thymus cancer	0.00997	0.00997	CcSEcCtD
Salbutamol—Abdominal pain upper—Octreotide—thymus cancer	0.00954	0.00954	CcSEcCtD
Salbutamol—Cramp muscle—Octreotide—thymus cancer	0.00941	0.00941	CcSEcCtD
Salbutamol—Nasopharyngitis—Octreotide—thymus cancer	0.00934	0.00934	CcSEcCtD
Salbutamol—Abdominal distension—Octreotide—thymus cancer	0.00909	0.00909	CcSEcCtD
Salbutamol—Asthma—Octreotide—thymus cancer	0.00903	0.00903	CcSEcCtD
Salbutamol—Influenza—Octreotide—thymus cancer	0.00903	0.00903	CcSEcCtD
Salbutamol—Bronchospasm—Octreotide—thymus cancer	0.00888	0.00888	CcSEcCtD
Salbutamol—Sweating increased—Octreotide—thymus cancer	0.00879	0.00879	CcSEcCtD
Salbutamol—Bronchitis—Octreotide—thymus cancer	0.00868	0.00868	CcSEcCtD
Salbutamol—Dysuria—Octreotide—thymus cancer	0.00844	0.00844	CcSEcCtD
Salbutamol—Upper respiratory tract infection—Octreotide—thymus cancer	0.00839	0.00839	CcSEcCtD
Salbutamol—Hyperglycaemia—Octreotide—thymus cancer	0.00814	0.00814	CcSEcCtD
Salbutamol—Drowsiness—Octreotide—thymus cancer	0.00805	0.00805	CcSEcCtD
Salbutamol—Neuropathy peripheral—Octreotide—thymus cancer	0.00789	0.00789	CcSEcCtD
Salbutamol—Jaundice—Octreotide—thymus cancer	0.00785	0.00785	CcSEcCtD
Salbutamol—Conjunctivitis—Octreotide—thymus cancer	0.00782	0.00782	CcSEcCtD
Salbutamol—Urinary tract infection—Octreotide—thymus cancer	0.00782	0.00782	CcSEcCtD
Salbutamol—Haematuria—Octreotide—thymus cancer	0.00767	0.00767	CcSEcCtD
Salbutamol—Epistaxis—Octreotide—thymus cancer	0.00759	0.00759	CcSEcCtD
Salbutamol—Sinusitis—Octreotide—thymus cancer	0.00755	0.00755	CcSEcCtD
Salbutamol—Rhinitis—Octreotide—thymus cancer	0.00724	0.00724	CcSEcCtD
Salbutamol—Hypoaesthesia—Octreotide—thymus cancer	0.00719	0.00719	CcSEcCtD
Salbutamol—Pharyngitis—Octreotide—thymus cancer	0.00717	0.00717	CcSEcCtD
Salbutamol—Tinnitus—Octreotide—thymus cancer	0.00674	0.00674	CcSEcCtD
Salbutamol—Flushing—Octreotide—thymus cancer	0.00671	0.00671	CcSEcCtD
Salbutamol—Cardiac disorder—Octreotide—thymus cancer	0.00671	0.00671	CcSEcCtD
Salbutamol—Immune system disorder—Octreotide—thymus cancer	0.00653	0.00653	CcSEcCtD
Salbutamol—Arrhythmia—Octreotide—thymus cancer	0.00646	0.00646	CcSEcCtD
Salbutamol—Mental disorder—Octreotide—thymus cancer	0.00633	0.00633	CcSEcCtD
Salbutamol—Malnutrition—Octreotide—thymus cancer	0.00629	0.00629	CcSEcCtD
Salbutamol—Flatulence—Octreotide—thymus cancer	0.0062	0.0062	CcSEcCtD
Salbutamol—Tension—Octreotide—thymus cancer	0.00617	0.00617	CcSEcCtD
Salbutamol—Nervousness—Octreotide—thymus cancer	0.00611	0.00611	CcSEcCtD
Salbutamol—Back pain—Octreotide—thymus cancer	0.00608	0.00608	CcSEcCtD
Salbutamol—Muscle spasms—Octreotide—thymus cancer	0.00605	0.00605	CcSEcCtD
Salbutamol—Tremor—Octreotide—thymus cancer	0.00589	0.00589	CcSEcCtD
Salbutamol—Ill-defined disorder—Octreotide—thymus cancer	0.00584	0.00584	CcSEcCtD
Salbutamol—Agitation—Octreotide—thymus cancer	0.00578	0.00578	CcSEcCtD
Salbutamol—Malaise—Octreotide—thymus cancer	0.00567	0.00567	CcSEcCtD
Salbutamol—Vertigo—Octreotide—thymus cancer	0.00565	0.00565	CcSEcCtD
Salbutamol—Syncope—Octreotide—thymus cancer	0.00564	0.00564	CcSEcCtD
Salbutamol—Palpitations—Octreotide—thymus cancer	0.00556	0.00556	CcSEcCtD
Salbutamol—Loss of consciousness—Octreotide—thymus cancer	0.00553	0.00553	CcSEcCtD
Salbutamol—Cough—Octreotide—thymus cancer	0.00549	0.00549	CcSEcCtD
Salbutamol—Hypertension—Octreotide—thymus cancer	0.00543	0.00543	CcSEcCtD
Salbutamol—Arthralgia—Octreotide—thymus cancer	0.00536	0.00536	CcSEcCtD
Salbutamol—Chest pain—Octreotide—thymus cancer	0.00536	0.00536	CcSEcCtD
Salbutamol—Myalgia—Octreotide—thymus cancer	0.00536	0.00536	CcSEcCtD
Salbutamol—Anxiety—Octreotide—thymus cancer	0.00534	0.00534	CcSEcCtD
Salbutamol—Discomfort—Octreotide—thymus cancer	0.00529	0.00529	CcSEcCtD
Salbutamol—Dry mouth—Octreotide—thymus cancer	0.00524	0.00524	CcSEcCtD
Salbutamol—Anaphylactic shock—Octreotide—thymus cancer	0.00513	0.00513	CcSEcCtD
Salbutamol—Oedema—Octreotide—thymus cancer	0.00513	0.00513	CcSEcCtD
Salbutamol—Infection—Octreotide—thymus cancer	0.0051	0.0051	CcSEcCtD
Salbutamol—Shock—Octreotide—thymus cancer	0.00505	0.00505	CcSEcCtD
Salbutamol—Nervous system disorder—Octreotide—thymus cancer	0.00503	0.00503	CcSEcCtD
Salbutamol—Tachycardia—Octreotide—thymus cancer	0.00501	0.00501	CcSEcCtD
Salbutamol—Skin disorder—Octreotide—thymus cancer	0.00499	0.00499	CcSEcCtD
Salbutamol—Hyperhidrosis—Octreotide—thymus cancer	0.00496	0.00496	CcSEcCtD
Salbutamol—Anorexia—Octreotide—thymus cancer	0.00489	0.00489	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00468	0.00468	CcSEcCtD
Salbutamol—Insomnia—Octreotide—thymus cancer	0.00464	0.00464	CcSEcCtD
Salbutamol—Paraesthesia—Octreotide—thymus cancer	0.00461	0.00461	CcSEcCtD
Salbutamol—Dyspnoea—Octreotide—thymus cancer	0.00458	0.00458	CcSEcCtD
Salbutamol—Somnolence—Octreotide—thymus cancer	0.00456	0.00456	CcSEcCtD
Salbutamol—Dyspepsia—Octreotide—thymus cancer	0.00452	0.00452	CcSEcCtD
Salbutamol—Decreased appetite—Octreotide—thymus cancer	0.00446	0.00446	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Octreotide—thymus cancer	0.00443	0.00443	CcSEcCtD
Salbutamol—Fatigue—Octreotide—thymus cancer	0.00443	0.00443	CcSEcCtD
Salbutamol—Constipation—Octreotide—thymus cancer	0.00439	0.00439	CcSEcCtD
Salbutamol—Pain—Octreotide—thymus cancer	0.00439	0.00439	CcSEcCtD
Salbutamol—Feeling abnormal—Octreotide—thymus cancer	0.00423	0.00423	CcSEcCtD
Salbutamol—Gastrointestinal pain—Octreotide—thymus cancer	0.0042	0.0042	CcSEcCtD
Salbutamol—Urticaria—Octreotide—thymus cancer	0.00408	0.00408	CcSEcCtD
Salbutamol—Abdominal pain—Octreotide—thymus cancer	0.00406	0.00406	CcSEcCtD
Salbutamol—Body temperature increased—Octreotide—thymus cancer	0.00406	0.00406	CcSEcCtD
Salbutamol—Hypersensitivity—Octreotide—thymus cancer	0.00378	0.00378	CcSEcCtD
Salbutamol—Asthenia—Octreotide—thymus cancer	0.00368	0.00368	CcSEcCtD
Salbutamol—Pruritus—Octreotide—thymus cancer	0.00363	0.00363	CcSEcCtD
Salbutamol—Diarrhoea—Octreotide—thymus cancer	0.00351	0.00351	CcSEcCtD
Salbutamol—Dizziness—Octreotide—thymus cancer	0.00339	0.00339	CcSEcCtD
Salbutamol—Vomiting—Octreotide—thymus cancer	0.00326	0.00326	CcSEcCtD
Salbutamol—Rash—Octreotide—thymus cancer	0.00324	0.00324	CcSEcCtD
Salbutamol—Dermatitis—Octreotide—thymus cancer	0.00323	0.00323	CcSEcCtD
Salbutamol—Headache—Octreotide—thymus cancer	0.00322	0.00322	CcSEcCtD
Salbutamol—Nausea—Octreotide—thymus cancer	0.00305	0.00305	CcSEcCtD
